{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T03:30:16Z","timestamp":1793503816090,"version":"4.5.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,7,21]],"date-time":"2021-07-21T00:00:00Z","timestamp":1626825600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,7,21]],"date-time":"2021-07-21T00:00:00Z","timestamp":1626825600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100008719","name":"Movember Foundation","doi-asserted-by":"publisher","award":["250-20"],"award-info":[{"award-number":["250-20"]}],"id":[{"id":"10.13039\/100008719","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>To report patient activation, which is the knowledge, skills, and confidence in self-managing health conditions, and patient-reported outcomes of men after prostate cancer treatment from a community pharmacy lifestyle intervention.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The 3-month lifestyle intervention was delivered to 116 men in nine community pharmacies in the UK. Patient Activation Measure (PAM) was assessed at baseline, 3 and 6\u00a0months. Prostate cancer-related function and quality of life were assessed using the European Prostate Cancer Index Composite (EPIC-26) and EuroQOL 5-dimension 5-level (EQ5D-5L) questionnaires at baseline and 6\u00a0months. Lifestyle assessments included Mediterranean Diet Adherence Screener (MEDAS) at baseline, 3 and 6\u00a0months and Godin Leisure Time Exercise Questionnaire (GLTEQ) at baseline and 3\u00a0months.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>PAM score increased from 62 [95% CI 59\u201365] at baseline to 66 [64\u201369] after the intervention (<jats:italic>p<\/jats:italic>\u2009=\u20090.001) and remained higher at 6\u00a0months (<jats:italic>p<\/jats:italic>\u2009=\u20090.008). Scores for all the EPIC-26 domains (urinary, bowel and hormonal) were high at both assessments, indicating good function (between 74 [70\u201378] and 89 [86\u201391]), except sexual domain, where scores were much lower (21 [17\u201325] at baseline, increasing to 24 [20\u201328] at 6\u00a0months (<jats:italic>p<\/jats:italic>\u2009=\u20090.012)). In EQ5D-5L, 3% of men [1\u20139] reported self-care problems, while 50% [41\u201360] reported pain and discomfort, and no significant changes over time. Men who received androgen deprivation therapy, compared with those who did not, reported higher (better) urinary incontinence scores (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001), but lower (worse) scores in the urinary irritative\/obstructive (<jats:italic>p<\/jats:italic>\u2009=\u20090.003), bowel (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001) and hormonal (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001) domains. Poor sexual function was common across all age groups irrespective of prostate cancer treatment.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The intervention led to significant improvements in patient activation, exercise and diet. Community pharmacy could deliver effective services to address sexual dysfunction, pain and discomfort which are common after prostate cancer.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00520-021-06404-5","type":"journal-article","created":{"date-parts":[[2021,7,21]],"date-time":"2021-07-21T01:02:36Z","timestamp":1626829356000},"page":"347-358","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Patient activation and patient-reported outcomes of men from a community pharmacy lifestyle intervention after prostate cancer treatment"],"prefix":"10.1007","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4849-2430","authenticated-orcid":false,"given":"Agnieszka","family":"Lemanska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Poole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph","family":"Manders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachariah","family":"Nazar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Noble","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Saxton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Warner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce A.","family":"Griffin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Faithfull","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,21]]},"reference":[{"issue":"10","key":"6404_CR1","doi-asserted-by":"publisher","first-page":"2741","DOI":"10.1007\/s11136-019-02212-x","volume":"28","author":"S Wilding","year":"2019","unstructured":"Wilding S et al (2019) Cancer-related symptoms, mental well-being, and psychological distress in men diagnosed with prostate cancer treated with androgen deprivation therapy. Qual Life Res 28(10):2741\u20132751","journal-title":"Qual Life Res"},{"key":"6404_CR2","unstructured":"Stout NL et al. A systematic review of rehabilitation and exercise recommendations in oncology guidelines. CA: A Cancer J Clin. n\/a(n\/a)"},{"key":"6404_CR3","unstructured":"NICE, Prostate cancer: diagnosis and management. Clinical guideline [CG175] Published January 2014 https:\/\/www.nice.org.uk\/guidance\/cg175. Accessed Nov 2017."},{"issue":"12","key":"6404_CR4","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/S1470-2045(15)00205-3","volume":"16","author":"G Rubin","year":"2015","unstructured":"Rubin G et al (2015) The expanding role of primary care in cancer control. Lancet Oncol 16(12):1231\u20131272","journal-title":"Lancet Oncol"},{"key":"6404_CR5","unstructured":"A five-year framework for GP contract reform to implement The NHS Long Term Plan (2019) https:\/\/www.england.nhs.uk\/publication\/gp-contract-five-year-framework\/. Accessed Nov"},{"issue":"5","key":"6404_CR6","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.cptl.2014.05.019","volume":"6","author":"J Addo-Atuah","year":"2014","unstructured":"Addo-Atuah J (2014) Making a case for a public health orientation in global pharmacy education and practice in the context of the Millennium Development Goals (MDGs). Curr Pharm Teach Learn 6(5):723\u2013729","journal-title":"Curr Pharm Teach Learn"},{"key":"6404_CR7","unstructured":"Agomo C et al (2018) Community pharmacists' contribution to public health: assessing the global evidence base. Clin Pharm 10(4)"},{"issue":"2","key":"6404_CR8","doi-asserted-by":"publisher","first-page":"e009828","DOI":"10.1136\/bmjopen-2015-009828","volume":"6","author":"TJ Brown","year":"2016","unstructured":"Brown TJ et al (2016) Community pharmacy-delivered interventions for public health priorities: a systematic review of interventions for alcohol reduction, smoking cessation and weight management, including meta-analysis for smoking cessation. BMJ Open 6(2):e009828","journal-title":"BMJ Open"},{"issue":"12","key":"6404_CR9","doi-asserted-by":"publisher","first-page":"3146","DOI":"10.1080\/21645515.2016.1215393","volume":"12","author":"RC Burson","year":"2016","unstructured":"Burson RC et al (2016) Community pharmacies as sites of adult vaccination: a systematic review. Hum Vaccines Immunother 12(12):3146\u20133159","journal-title":"Hum Vaccines Immunother"},{"issue":"5","key":"6404_CR10","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.healthpol.2015.02.007","volume":"119","author":"E Mossialos","year":"2015","unstructured":"Mossialos E et al (2015) From \u201cretailers\u201d to health care providers: transforming the role of community pharmacists in chronic disease management. Health Policy 119(5):628\u2013639","journal-title":"Health Policy"},{"key":"6404_CR11","doi-asserted-by":"crossref","unstructured":"Goode, JV et al (2019) Community-based pharmacy practice innovation and the role of the community-based pharmacist practitioner in the United States. Pharmacy (Basel) 7(3)","DOI":"10.3390\/pharmacy7030106"},{"issue":"5","key":"6404_CR12","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1111\/ijpp.12251","volume":"24","author":"S Pearce","year":"2016","unstructured":"Pearce S et al (2016) The case for targeting community pharmacy-led health improvement: Findings from a skin cancer campaign in Wales. Int J Pharm Pract 24(5):333\u2013340","journal-title":"Int J Pharm Pract"},{"issue":"2","key":"6404_CR13","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1592\/phco.21.2.243.34100","volume":"21","author":"JT Giles","year":"2001","unstructured":"Giles JT et al (2001) Results of a community pharmacy-based breast cancer risk-assessment and education program. Pharmacotherapy 21(2):243\u2013253","journal-title":"Pharmacotherapy"},{"issue":"6","key":"6404_CR14","doi-asserted-by":"publisher","first-page":"e025114","DOI":"10.1136\/bmjopen-2018-025114","volume":"9","author":"A Lemanska","year":"2019","unstructured":"Lemanska A et al (2019) Community pharmacy lifestyle intervention to increase physical activity and improve cardiovascular health of men with prostate cancer: a phase II feasibility study. BMJ Open 9(6):e025114","journal-title":"BMJ Open"},{"key":"6404_CR15","unstructured":"UK physical activity guidelines. Guidance from the Chief Medical Office (CMO) on how much physical activity people should be doing with supporting documents, 2011. https:\/\/www.gov.uk\/government\/publications\/uk-physical-activity-guidelines. Accessed March 2018"},{"issue":"3","key":"6404_CR16","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.eururo.2014.08.075","volume":"67","author":"NE Martin","year":"2015","unstructured":"Martin NE et al (2015) Defining a standard set of patient-centered outcomes for men with localized prostate cancer. Eur Urol 67(3):460\u2013467","journal-title":"Eur Urol"},{"issue":"4 Pt 1","key":"6404_CR17","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1111\/j.1475-6773.2004.00269.x","volume":"39","author":"JH Hibbard","year":"2004","unstructured":"Hibbard JH et al (2004) Development of the Patient Activation Measure (PAM): conceptualizing and measuring activation in patients and consumers. Health Serv Res 39(4 Pt 1):1005\u20131026","journal-title":"Health Serv Res"},{"key":"6404_CR18","unstructured":"Insigina Health, Patient activation measure (PAM) 13 TM Licence Materials copyright, Insigna Health: LLC, 2011"},{"issue":"6","key":"6404_CR19","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.3945\/jn.110.135566","volume":"141","author":"H Schroder","year":"2011","unstructured":"Schroder H et al (2011) A short screener is valid for assessing Mediterranean diet adherence among older Spanish men and women. J Nutr 141(6):1140\u20131145","journal-title":"J Nutr"},{"issue":"1","key":"6404_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7326\/0003-4819-145-1-200607040-00004","volume":"145","author":"R Estruch","year":"2006","unstructured":"Estruch R et al (2006) Effects of a Mediterranean-style diet on cardiovascular risk factors: a randomized trial. Ann Intern Med 145(1):1\u201311","journal-title":"Ann Intern Med"},{"issue":"5","key":"6404_CR21","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1097\/HJR.0b013e328308ba61","volume":"15","author":"A S\u00e1nchez-Ta\u00ednta","year":"2008","unstructured":"S\u00e1nchez-Ta\u00ednta A et al (2008) Adherence to a Mediterranean-type diet and reduced prevalence of clustered cardiovascular risk factors in a cohort of 3,204 high-risk patients. Eur J Cardiovasc Prev Rehabil 15(5):589\u2013593","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"issue":"3","key":"6404_CR22","first-page":"141","volume":"10","author":"G Godin","year":"1985","unstructured":"Godin G, Shephard RJ (1985) A simple method to assess exercise behavior in the community. Can J Appl Sport Sci 10(3):141\u2013146","journal-title":"Can J Appl Sport Sci"},{"key":"6404_CR23","doi-asserted-by":"crossref","unstructured":"Godin G, Shephard RJ (1997) Godin Leisure-Time Exercise Questionnaire. Medicine and Science in Sports and Exercise. 29 June Supplement: S36-S38. Med Sci Sports Exerc S36-S38","DOI":"10.1097\/00005768-199706001-00009"},{"issue":"5","key":"6404_CR24","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/j.urology.2010.01.027","volume":"76","author":"KM Szymanski","year":"2010","unstructured":"Szymanski KM et al (2010) Development and validation of an abbreviated version of the expanded prostate cancer index composite instrument for measuring health-related quality of life among prostate cancer survivors. Urology 76(5):1245\u20131250","journal-title":"Urology"},{"key":"6404_CR25","unstructured":"The University of Michigan (2002) Scoring Instructions for the Expanded Prostate cancer Index Composite Short Form (EPIC-26). https:\/\/medicine.umich.edu\/sites\/default\/files\/content\/downloads\/Scoring%20Instructions%20for%20the%20EPIC%2026.pdf. Accessed Oct 2020"},{"issue":"5","key":"6404_CR26","doi-asserted-by":"publisher","first-page":"337","DOI":"10.3109\/07853890109002087","volume":"33","author":"R Rabin","year":"2001","unstructured":"Rabin R, de Charro F (2001) EQ-5D: a measure of health status from the EuroQol Group. Ann Med 33(5):337\u2013343","journal-title":"Ann Med"},{"key":"6404_CR27","unstructured":"The EuroQOL group (2005) EQ-5D-5L user guide. Basic information on how to use the EQ-5D-5L instrument. https:\/\/euroqol.org\/publications\/user-guides\/. Accessed Oct 2020"},{"issue":"1","key":"6404_CR28","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/hec.3564","volume":"27","author":"NJ Devlin","year":"2018","unstructured":"Devlin NJ et al (2018) Valuing health-related quality of life: an EQ-5D-5L value set for England. Health Econ 27(1):7\u201322","journal-title":"Health Econ"},{"key":"6404_CR29","unstructured":"Insignia Health (2016) Patient activation measure (PAM) survey level. http:\/\/www.insigniahealth.com\/products\/pam-survey. Accessed Oct 2020"},{"issue":"1","key":"6404_CR30","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.urology.2014.08.044","volume":"85","author":"TA Skolarus","year":"2015","unstructured":"Skolarus TA et al (2015) Minimally important difference for the Expanded Prostate Cancer Index Composite Short Form. Urology 85(1):101\u2013105","journal-title":"Urology"},{"issue":"7","key":"6404_CR31","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1080\/0284186X.2018.1438654","volume":"57","author":"HC Melissant","year":"2018","unstructured":"Melissant HC et al (2018) \u201cOncokompas\u201d, a web-based self-management application to support patient activation and optimal supportive care: a feasibility study among breast cancer survivors. Acta Oncol 57(7):924\u2013934","journal-title":"Acta Oncol"},{"key":"6404_CR32","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.eururo.2015.10.047","volume":"69","author":"L Bourke","year":"2016","unstructured":"Bourke L et al (2016) Exercise for men with prostate cancer: a systematic review and meta-analysis. Eur Urol 69:693\u2013703","journal-title":"Eur Urol"},{"issue":"1","key":"6404_CR33","doi-asserted-by":"publisher","first-page":"e000032","DOI":"10.1136\/ihj-2019-000032","volume":"2","author":"R Kearns","year":"2020","unstructured":"Kearns R et al (2020) Implementing the patient activation measure (PAM) in clinical settings for patients with chronic conditions: a scoping review. Integr Healthc J 2(1):e000032","journal-title":"Integr Healthc J"},{"issue":"7","key":"6404_CR34","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.pec.2017.03.019","volume":"100","author":"JH Hibbard","year":"2017","unstructured":"Hibbard JH, Mahoney E, Sonet E (2017) Does patient activation level affect the cancer patient journey? Patient Educ Couns 100(7):1276\u20131279","journal-title":"Patient Educ Couns"},{"key":"6404_CR35","doi-asserted-by":"publisher","first-page":"5125","DOI":"10.2147\/CMAR.S170064","volume":"10","author":"E Finne","year":"2018","unstructured":"Finne E et al (2018) Behavior change techniques for increasing physical activity in cancer survivors: a systematic review and meta-analysis of randomized controlled trials. Cancer Manag Res 10:5125\u20135143","journal-title":"Cancer Manag Res"},{"issue":"8","key":"6404_CR36","doi-asserted-by":"publisher","first-page":"e43134","DOI":"10.1371\/journal.pone.0043134","volume":"7","author":"MA Mart\u00ednez-Gonz\u00e1lez","year":"2012","unstructured":"Mart\u00ednez-Gonz\u00e1lez MA et al (2012) A 14-item Mediterranean diet assessment tool and obesity indexes among high-risk subjects: the PREDIMED trial. PLoS One 7(8):e43134","journal-title":"PLoS One"},{"issue":"11","key":"6404_CR37","doi-asserted-by":"publisher","first-page":"9154","DOI":"10.3390\/nu7115457","volume":"7","author":"S Eguaras","year":"2015","unstructured":"Eguaras S et al (2015) Better adherence to the Mediterranean diet could mitigate the adverse consequences of obesity on cardiovascular disease: the SUN prospective cohort. Nutrients 7(11):9154\u20139162","journal-title":"Nutrients"},{"issue":"3","key":"6404_CR38","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/S1470-2045(18)30780-0","volume":"20","author":"A Downing","year":"2019","unstructured":"Downing A et al (2019) Quality of life in men living with advanced and localised prostate cancer in the UK: a population-based study. The Lancet Oncology 20(3):436\u2013447","journal-title":"The Lancet Oncology"},{"key":"6404_CR39","doi-asserted-by":"publisher","first-page":"m3503","DOI":"10.1136\/bmj.m3503","volume":"371","author":"CG Mazariego","year":"2020","unstructured":"Mazariego CG et al (2020) Fifteen year quality of life outcomes in men with localised prostate cancer: population based Australian prospective study. BMJ 371:m3503","journal-title":"BMJ"},{"key":"6404_CR40","unstructured":"The EuroQol Group\u2019s International Task Force on Self-Reported Health (2004) Measuring self-reported population health: an international perspective based on EQ-5D https:\/\/euroqol.org\/wp-content\/uploads\/2016\/10\/Measuring_Self-Reported_Population_Health_-_An_International_Perspective_based_on_EQ-5D.pdf. Accessed Oct 2020"},{"issue":"6B","key":"6404_CR41","doi-asserted-by":"publisher","first-page":"E36","DOI":"10.1111\/bju.13179","volume":"117","author":"S Carlsson","year":"2016","unstructured":"Carlsson S et al (2016) Population-based study of long-term functional outcomes after prostate cancer treatment. BJU Int 117(6B):E36\u2013E45","journal-title":"BJU Int"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-021-06404-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-021-06404-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-021-06404-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T07:13:02Z","timestamp":1638342782000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-021-06404-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,21]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["6404"],"URL":"https:\/\/doi.org\/10.1007\/s00520-021-06404-5","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,21]]},"assertion":[{"value":"23 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study received ethics approval from the NHS Health Research Authority South Central-Berkshire B Research Ethics Committee (16\/SC\/0069). Research governance approval was provided by the Wessex Primary Care Research Support Service (IRAS ID 193263).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All participants provided written informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"SF is a trustee of PCUK and chair of NCRI late consequences research subgroup. No other authors declare a conflict of interest.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}